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Abstract
The Intensive Care Unit (ICU) is a hospital depart-
ment where machine learning has the potential to
provide valuable assistance in clinical decision
making. Classical machine learning models usu-
ally only provide point-estimates and no uncer-
tainty of predictions. In practice, uncertain pre-
dictions should be presented to doctors with extra
care in order to prevent potentially catastrophic
treatment decisions. In this work we show how
Bayesian modelling and the predictive uncertainty
that it provides can be used to mitigate risk of
misguided prediction and to detect out-of-domain
examples in a medical setting. We derive analyti-
cally a bound on the prediction loss with respect
to predictive uncertainty. The bound shows that
uncertainty can mitigate loss. Furthermore, we ap-
ply a Bayesian Neural Network to the MIMIC-III
dataset, predicting risk of mortality of ICU pa-
tients. Our empirical results show that uncertainty
can indeed prevent potential errors and reliably
identifies out-of-domain patients. These results
suggest that Bayesian predictive uncertainty can
greatly improve trustworthiness of machine learn-
ing models in high-risk settings such as the ICU.
1. Introduction
The Intensive Care Unit (ICU) is a resource-intensive en-
vironment where patients receive care that is not readily
available elsewhere in the hospital. ICU patients usually
are in life-threatening conditions. Therefore, adequate as-
sessment of illness severity and expected effectiveness of
interventions is of utmost importance for clinical decision
making. Recent advancements in machine learning have
cleared the path to deployment of machine learning based
decision support software systems in critical areas like the
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ICU. Examples are predicting risk of readmission after dis-
charge (Thoral et al., 2018), optimizing sepsis treatment
(Raghu et al., 2017), or predicting mortality risk given the
current state of the patient (Pirracchio et al., 2015). While
these applications have proven to be effective, model trust-
worthiness remains elusive. Most machine learning models
only provide point estimates of their parameters and corre-
sponding predictions. A recent study has shown that these
models can output high-risk predictions on datapoints that
lie far from their observed dataset (Nguyen et al., 2015).
Especially in a critical area like the ICU these flaws could
result in catastrophes. For effective machine learning based
decision support, we think it is crucial that machine learn-
ing methods output uncertainty estimates beside predictions.
Bayesian modelling has the desirable property of expressing
predictive uncertainty through stochasticity in its parame-
ters. In this work, we show how Bayesian Neural Networks,
through predictive uncertainty (hereafter referred to as un-
certainty), can correctly identify predictions that are likely
to be misguided. When the model encounters a datapoint
that lies far from its observed set, a practitioner can be no-
tified through the model’s uncertainty and observe that the
patient has a combination of symptoms that hitherto has not
been seen. Therefore, the practitioner should proceed with
care.
In previous work, Leibig et al. (2017) are among the first
to apply model uncertainty to healthcare by diagnosing dia-
betic retinopathy from fundus images. Similarly, Nair et al.
(2018); Wang et al. (2019); Orlando et al. (2019) also es-
timate uncertainty to image analysis using MC Dropout
(Gal, 2016). We extend on previous work by making the
following constributions.
1. We provide mathematical bounds on the obtainable
loss with respect to uncertainty.
2. Through these bounds, model performance is directly
related to uncertainty. Uncertainty prevents high-loss
prediction errors.
3. We show that BNNs can identify out-of-domain pa-
tients competently in a real use-case.
Additionally, we are (to our best knowledge) novel in the
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approach of using Bayes By Backprop (Blundell et al.,
2015) instead of MC Dropout to estimate model distribu-
tion parameters directly. This choice has two motivations.
First, MC Dropout rates have to be carefully adjusted to
obtain well-calibrated uncertainties. This requires tuning all
dropout probabilities, which is unfeasible for deep neural
networks. Second, the MC dropout approximate posterior
does not contract with more data, and therefore the approach
has been questioned (Osband, 2016). We also extend on ear-
lier publications by applying Bayesian uncertainty to (ICU)
signal processing.
The rest of the paper is structured as follows. In section 2 we
discourse required background knowledge. In section 3 we
elaborate on methodological decisions for signal processing
and modelling. In section 4 we provide an overview of
the results, showing that model uncertainty can mitigate
the prediction loss and how uncertainty relates to out-of-
domain observations. In section 5 we conclude and provide
suggestions for future research directions.
2. Background
In this section we summarize important background theory
about Bayesian modelling.
2.1. Bayesian Neural Networks
In deterministic modelling, given a dataset of observations
X = {x1, . . . ,xN} and labels y = {y1, . . . , yN}, we
restrict model parametersω to a point estimate and optimize
the likelihood function p(y|X,ω) directly. That is, we try
to find
w∗ = argmax
ω
P (y|X,ω). (1)
To capture model uncertainty, we strive to find the posterior
distribution over the model parameters:
P (ω|X,y) = P (y|X,ω)P (ω)
P (y|X) , (2)
where P (ω) is a prior. The marginal likelihood P (y|X) is
computed by marginalisation:
∫
ω
P (y|X,ω)P (ω). Given
many continuous model parameters this term cannot be
evaluated analytically, which is the case when ω are the
parameters of a (deep) neural network. Consequently, the
posterior is intractable as well. Therefore, we approximate
it with a tractable variational distribution qθ(ω) through a
procedure called variational inference (Hinton & van Camp,
1993). The goal is to minimize the KL divergence between
the true and approximate posterior:
θ∗ = argmin
θ
KL (qθ(ω)||P (ω|X,y)) . (3)
This KL divergence, too, is analytically intractable. In-
stead, we can minimize it by maximizing the evidence lower
bound:
LV I(θ):=
∫
ω
qθ(ω) logP (y|X,ω)− KL(qθ(ω)||P (ω))
(4)
= logP (y|X)− KL (qθ(ω)||P (ω|X,y))
Since the KL-divergence is non-negative, the evidence lower
bound floors the marginal likelihood. Thus, we are able to
minimize the gap between the true and approximate poste-
rior.
In this paper, we used the approach of Blundell et al. (2015),
coined Bayes By Backprop (BBB), to maximize the evi-
dence lower bound. Predictions for a data point xi were
made by sampling model parameters from the variational
posterior distribution qθ(ω) and taking the mean of the pre-
dictions of all sampled models. That is:
P (yi|xi) = 1
T
T∑
t=1
P (yit|f ωˆt(xi)) (5)
with ωˆt ∼ q∗θ(ω). Predictive uncertainty was computed as
the variance in the predictions:
V ar(yi|xi) = 1
T
T∑
t=1
(P (yi|xi)− P (yi|f ωˆt(xi))2 (6)
3. Methods
3.1. Data and Preprocessing
Data was obtained from the Multiparameter Intelligent Mon-
itoring in Intensive Care (MIMIC-III v1.4) database (John-
son et al., 2016). This dataset contains signal data for 46,520
patients and 58,976 ICU admissions. 7, 821 of the patients
in the MIMIC-III dataset are newborns; these were excluded
from the dataset as newborns come with different character-
istics and treatment requirements. For each patient, features
were constructed by aggregating relevant clinical informa-
tion, lab values and vital signs. The objective of the model
was to find patients that have a high risk of mortality dur-
ing the admission. More information on the task and data
processing is included in the supplementary material.
3.2. Model Architecture
Following Blundell et al. (2015), we used a Gaussian scale
mixture as our prior. We used two 128-neuron hidden layers,
ReLU intermediate activation and Sigmoid final activation
to obtain the probability distribution P (yi|fω(xi)). All
weight distributions were initialized with µ ∼ U(−.2, .2)
and ρ ∼ U(−5,−4). Adam was used as the optimizer with
the configurations as suggested by the authors (Kingma &
Ba, 2014).1
1Code is available at https://github.com/Pacmed/
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Figure 1. The reachable loss region in a Bayesian binary classifica-
tion problem.
(a)
(b)
Figure 2. Cumulative prediction loss (y-axis) related to the amount
of uncertain testing data included in the analysis (x-axis). The
uncertainty effectively mitigates prediction loss for both the BNN
(a) and the Gradient Boosting model (b).
4. Results
We discuss our results in the following two subsections.
4.1. Uncertainty Mitigates Prediction Loss
In the supplementary material we derive the upper and lower
bounds of the binary cross-entropy loss L(yi|xi) with re-
spect to uncertainty:
− log
(
1
2
+
1
2
√
1− 4 · V ar(yi|xi)
)
≤ L(yi|xi) ≤ − log
(
1
2
− 1
2
√
1− 4 · V ar(yi|xi)
)
.
(7)
These are depicted in figure 1. In the supplementary ma-
terial we show how the data follows these bounds. Areas
of both low and high loss cannot be reached with high un-
certainty. In other words, when the variational posterior
distribution is a good approximation of the true posterior,
far-from-domain examples that cause high uncertainty will
mathematically drive the loss away from the extreme values.
From this line of thought, we hypothesize that uncertainty
is able to mitigate prediction loss. Deterministic models
can output very confident predictions on inputs that lie far
from their training domain, yielding high performance loss.
From equation 7 we see that this is not possible for a BNN.
Additionally, the cause of a highly certain wrong prediction
may be due to errors in the data, for example due to mis-
labelled observations. If the variational posteriors is not a
good approximation of the true posterior, low uncertainty
can still be achieved on wrong predictions, leading to bad
consequences. Therefore, we evaluate empirically.
Figure 2 illustrates how uncertainty relates to predictive
performance. When the observations {x1, . . . ,xN} are
sorted according to their predictive uncertainty, it can be
seen that the loss increases superlinearly for each additional
data point included. That is, the most uncertain 20% of the
data contribute about 20 times the loss the most certain 20%
do. In the supplementary material, we show that for the
20% most certain data the area under the receiver operat-
ing characteristic curve (AUROC) approaches unity. Thus,
low-uncertainty patients are more often classified correctly.
Therefore, by restricting classification to certain data points,
we can effectively employ predictive uncertainty to calibrate
the performance of the model.
A peculiar finding is depicted in figure 2b. We observe
that uncertainty generalizes to a gradient boosting decision
tree model, trained on the same data. In the case of tabu-
lar data like MIMIC, this result could prove to be particu-
larly interesting, as neural networks are often outperformed
by other non-linear models in similar tasks (Ferna´ndez-
Delgado et al., 2014). This observation could mean that
a Bayesian model can be deployed for the sole purpose of
its uncertainty output, leaving the classification task to a
second higher-performing model. The total obtained cumu-
lative loss is lower for the tree-based model, meaning that it
had more confident correct predictions. This is likely due to
the fact that the prediction risk for the decision tree is not
mathematically bound to uncertainty. Note that we have not
investigated when this does or does not hold. This remains
worthy of further investigation.
4.2. Detecting Out-of-Domain Patients
Plotting the relationship between predictions and uncertainty
results in the moon-shaped scatter plot depicted in figure 3a.
This corresponds to the intuition given earlier, showing that
extreme predictions are only made on observations with low
uncertainty. In the central region of the graph, we see that
the uncertainty has a wider spread, meaning that there are
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(a)
(b)
Figure 3. In plot 3a we depict the predictive uncertainty (x-axis)
related to predictive uncertainty (y-axis). In plot 3b we see how
the BNN effectively identifies out-of-domain examples.
both observations with feature values occurring frequently
(low uncertainty) and patients with sets of features that lie
further from the previously observed domain. Most of the
mass expectedly concentrates around the surviving group of
patients.
In the medical field, research is often conducted on a biased
sample of the population of patients and therefore minorities
are underrepresented (Baird, 1999; Swanson & Ward, 1995;
Giuliano et al., 2000; Bonevski et al., 2014). Regrettably,
models and treatments are still applied to the true popula-
tion, including these minorities, which can lead to adverse
results. In the MIMIC dataset, there is a group of 7, 821
newborns. These were set aside as out-of-domain patients,
and excluded from training. We replaced obvious differ-
ences like weight and age with training data averages. We
observe in figure 3b that when the model is presented new-
borns, it becomes about 230% more uncertain on average.
This means that a high-uncertainty output can be used to
warn a practitioner that the (combination of) symptoms and
vital signs have rarely been observed before, and he or she
should proceed with care. A plot for the newborns similar
to figure 3a is given in the supplementary material. Since
the characteristics of newborns greatly differ from the rest
of the population, we also experimented with uncertainty on
ethnic minorities. Among others, Carson et al. (1999) inves-
tigated the differences in responses to heart failure therapies
between ethnicities. African American people did show
different responses as a result of different features compared
to the baseline. This motivated us to investigate model un-
certainty on such an ethnic minority. After setting it apart,
we observed that the BNN became 130% more uncertain
(p < .0001) on this group. Comparison to a determinis-
tic baseline on these tasks is given in the supplementary
material.
5. Conclusions
In this paper, we explored the application of Bayesian Neu-
ral Networks to improve the safety of machine-learning-
based clinical decision support tools in critical areas such
as the ICU. Following the findings of Blundell et al. (2015),
we trained a BNN on the MIMIC critical care dataset. The
objective of the model was to predict patient mortality given
clinical observations and lab values. We derived bounds
on cross-entropy loss with respect to predictive uncertainty.
Through these bounds, uncertainty is able to mitigate perfor-
mance risk and loss. Empirically, we showed that the loss of
test set predictions increased superlinearly when the patients
were sorted according to their corresponding uncertainty.
Secondly, the results reveal that the uncertainty of the pre-
dictions increases significantly on out-of-domain patients.
This suggests that in an applied setting a BNN can effec-
tively identify patients outside of its previously observed
domain. Overall, this work demonstrates that uncertainty is
effective in enhancing model trustworthiness and mitigating
prediction risk and loss in an critical setting like the ICU.
A mathematical intuition as to why uncertainty generalizes
to other models remains unclear. This can be an interesting
direction for future research.
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Figure 4. Illustration of how the data follows the bounds.
A.
In this section, we show the derivation of the bounds on
the binary cross-entropy criterion relating to predictive un-
certainty. Uncertainty is computed as the variance in the
predictions for each datapoint xi given T samples from
a Bayesian posterior P (ω|X,Y ). We start off with the
Bhatia-Davis inequality on variance given a distribution
maximum M and distribution minimum m:
σ2 ≤ (M − µ)(µ−m). (8)
Solving the equality case for µ,
µ2 − (M +m)µ+mM + σ2 = 0 (9)
µ =
M +m
2
± 1
2
√
(M −m)2 − 4σ2, (10)
gives us bounds for the mean with respect to the variance:
M +m
2
− 1
2
√
(M −m)2 − 4σ2 ≤ µ
≤ M +m
2
+
1
2
√
(M −m)2 − 4σ2. (11)
In our case µ = P (yi|xi) = 1T
∑T
t=1 P (yit|f ωˆt (xi),
σ2 = V ar(yi|xi) = 1T
∑T
t=1(P (yi|xi) − P (yi|f ωˆt (xi))2.
P (yit|fωt (xi)) is obtained from Sigmoid activation, there-
fore m = infω P (yi|xi) = 0 and M = supω P (yi|xi) =
1. Plugging these values and bounds in 11 into the binary
cross-entropy criterion,
L(yi|xi) =
{
log(P (yi|xi)), for y = 1
log(1− P (yi|xi)), for y = 0
}
, (12)
gives us a single bound (for both y = 1 and y = 0) on the
loss w.r.t. the uncertainty:
− log
(
1
2
+
1
2
√
1− 4 · V ar(yi|xi)
)
≤ L(yi|xi) ≤ − log
(
1
2
− 1
2
√
1− 4 · V ar(yi|xi)
)
.
(13)
In figure 4 we depict how the data follows these bounds.
B.
In figure 5 we show that the uncertainty can calibrate perfor-
mance in AUC for both a BNN (a) and a Gradient Boosting
model, motivating researching the usage of uncertainty in
combination with readily deployed models.
(a)
(b)
Figure 5. Predictive performance measured in AUROC (y-axis)
related to the amount of uncertain data included in the analysis
(x-axis).
C.
Patient data from the MIMIC-III database was used (John-
son et al., 2016). Vital signs, lab values and patient charac-
teristics that were most abundantly available were gathered.
Examples are blood pressure, potassium and age, respec-
tively. To keep interpretability, we restricted ourselves to 25
clinically relevant features. Arterial and non-invasive blood
pressures were combined, using the arterial blood pressure
where possible. Features that lied further than 8 interquar-
tile ranges were regarded as outliers and removed. Labels
were obtained directly from the MIMIC tables, regarding
expirement during the last hospital admission as a positive
label. 9,237 ICU stays were set apart for testing purposes,
leaving 36,944 patients for training.
D.
In figure 6 we observe how the predictions on the newborns
follow the same moon shape as the trained dataset. However,
average uncertainty is much higher.
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Figure 6.
E.
Following the approach of Hendrycks & Gimpel (2016), we
compare how well sigmoid probabilities are able to detect
correct classifications and out of domain patients compared
to Bayesian uncertainty.
Table 1. Comparison of error and success detection between deter-
ministic baseline and BNN.
MODEL AUROC AUPR SUCC AUPR ERR
BNN STD 83.7 97.7 32.6
NN SIGMOID 79.7 95.8 37.7
Table 2. Comparison of in and out of domain detection between
deterministic baseline and BNN.
MODEL AUROC AUPR IN AUPR OUT
BNN STD 75.9 80.5 69.7
NN SIGMOID 49.8 61.7 42.5
